ForSight is a medtech company that is developing a surgical robotic platform to deliver high precision and cost-effective vision-saving surgery.

ForSight's mission is to improve lives by restoring sight and bring hope to millions whose visions are impaired by common eye disease.

ForSight Robotics was founded in 2020 by Daniel Glozman, Fred Moll, Rony Abovitz, Moshe Shoham and Joseph Nathan. The company is headquartered in Netanya, Israel.

ForSight is transforming ophthalmic surgery with state-of-the-art robotics, advanced visualization, and data analytics. ForSight is developing Oryom, the first hybrid intraocular robotic ophthalmic platform, to advance ophthalmic surgery to treat a wide range of conditions including cataract, glaucoma, and other retinal diseases.

ForSight provides unprecedented dexterity and maneuverability, its surgical platform features miniature robotic microsurgical instruments capable of executing delicate tasks.

The ORYOM platform has already been used successfully in multiple cataract procedures on an animal eye model by a number of ophthalmic surgeons. The platform will automate the complex subtleties of ophthalmic surgery to treat the diseases underlying preventable blindness with an intuitive platform.